Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

AIDS Drugs Market Research Reports

Titlepublishedprice

Global Abacavir Sales Market Report 2017

By QYResearch Group
"...... illion USD), market share and growth rate of Abacavir for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeast Asia - India Global Abacavir......"
26-Apr-2017$4000

Global AIDS Partnering 2010 to 2017

By Current Partnering
"...... s understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. ¬ē Trends in partnering deals ¬ē Top deals by value ¬ē Deals listed by company A-Z, industry sector, sta......"
01-Apr-2017$1495

HIV Treatment Drugs Industry Forecasts - China Focus

By AMID
"...... of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growt......"
18-Mar-2017$1800

HIV Treatment Drugs Markets in China

By AMID
"...... onsumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major ind......"
18-Mar-2017$4000

HIV Treatment Drugs Companies in China

By AMID
"...... d economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. The Chinese economy maint......"
18-Mar-2017$1800

Integrase Inhibitors -Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Norvir SEC -Drug Insights, 2017

By Delve Insight
"...... lso provides the Norvir SEC sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Norvir SEC, patents information and exclusivity data, route of synthesis, co......"
01-Jan-2017$1000

Prezista -Drug Insights, 2017

By Delve Insight
"...... ovides the Prezista sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Prezista, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Maturation Inhibitors -Pipeline Insights, 2017

By Delve Insight
"...... -clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA d......"
01-Jan-2017$1250

Reyataz -Drug Insights, 2017

By Delve Insight
"...... des the Reyataz sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Reyataz, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Avail upto 25% Discount on below Publisher Reports.